Floatz logo

Lomustine

Leptomeningeal Metastasis From Malignant Melanoma

University Hospital, BonnSmall moleculePhase 1Dormant
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Leptomeningeal Metastasis From Malignant Melanoma cohort.

Asset / SponsorPhaseRating
Cytosin-Arabinosid
University Hospital, Bonn
Phase 1CC
her2bbζ/cd19t+ t cells
M.D. Anderson Cancer Center
Phase 1CC

Same molecule, other indications

Lomustine is also rated in:

central nervous system neoplasmDormant
BB
Indicative ·
68 / 100
View asset →
glioblastomaDormant
BB
Indicative ·
67 / 100
View asset →
diffuse large B-cell lymphomaDormant
BB
Indicative ·
66 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →